Tiny radioactive tracer reveals Drug's journey through the body

NCT ID NCT07494175

Ongoing Knowledge-focused Sponsor: Jiangsu HengRui Medicine Co., Ltd. Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early-stage study tracks a single injection of [14C]HRS-9190 in 6 healthy men to see how it is absorbed, broken down, and eliminated. The goal is to understand the drug's metabolism and excretion, not to treat any disease. Participants are closely monitored for side effects, but there is no expected health benefit.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

[14C]HRS-9190 (a radioactive-labeled drug for injection)

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY ADULT MALE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEALTHY ADULT MALE

Contacts and locations

Show contact details

Locations

First Affiliated Hospital of Shandong First Medical University (Shandong Provincial Qianfoshan Hospital)

Jinan, Shandong, 250014, China